** ICON Plc's shares ICLR.O jump 7.5% to $216 - biggest
pct. gain in nearly 3 months
** Clinical research organization sees 2023 adjusted profit
in range of $12.40 to $13.05 per share, above analysts' estimate
of $12.34 per share - Refinitiv IBES data urn:newsml:reuters.com:*:nBw7HG5YDa
** ICLR expects 2023 sales to be in range of $7.94 billion
to $8.34 billion vs analysts' estimate of $8.14 million -
Refinitiv IBES data
** Co reaffirms 2022 sales and adjusted profit guidance
** Including session gains, stock up ~11% YTD
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))